Fasting cut-points in determining prevalence of diabetes in an Arab population of the Middle East

Diabetes Research and Clinical Practice

Volumn 75, Issue 2, 2007, Pages 241-245

  Al Lawati, Jawad A ^a   Barakat, Mohammed N ^a  

^a MINISTRY OF HEALTH   (Oman)

Author keywords

Cut points; Diabetes; Oman; ROC curves

Indexed keywords

GLUCOSE;

ADULT; ARAB; ARTICLE; DIABETES MELLITUS; DIAGNOSTIC ACCURACY; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE EAST; OBESITY; ORAL GLUCOSE TOLERANCE TEST; PREVALENCE; RECEIVER OPERATING CHARACTERISTIC; RISK FACTOR; SEX DIFFERENCE;

ADULT; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS; FASTING; FEMALE; GLUCOSE INTOLERANCE; HEALTH SURVEYS; HUMANS; HYPERGLYCEMIA; ISLAM; MALE; MIDDLE EAST; OMAN; PREVALENCE; SENSITIVITY AND SPECIFICITY;

EID: 33845418433     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diabres.2006.06.018     Document Type: Article

References (23)

1. World Health Organization, Diabetes mellitus: Report of the WHO Study Group, 1985 (Technical Report Series No. 727).
2. American Diabetes Association. Report of the expert committee on diagnosis and classification of diabetes mellitus. Diabet. Care 20 7 (1997) 1183-1197
3. Alberti K.G., and Zimmet P.Z. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1. Diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet. Med. 15 7 (1998) 539-553
4. Bjornholt J.V., Erikssen G., Aaser E., Sandvik L., Nitter-Hauge S., Jervell J., et al. Fasting blood glucose: an underestimated risk factor for cardiovascular death. Results from a 22-year follow-up of healthy nondiabetic men. Diabetes Care 22 1 (1999) 45-49
5. Shaw J.E., Zimmet P.Z., McCarty D., and de Courten M. Type 2 diabetes worldwide according to the new classification and criteria. Diabetes Care 23 Suppl. 2 (2000) B5-B10
6. Asfour M.G., Lambourne A., Soliman A., Al-Behlani S., Al-Asfoor D., Bold A., et al. High prevalence of diabetes mellitus and impaired glucose tolerance in the Sultanate of Oman: results of the 1991 national survey. Diabet. Med. 12 12 (1995) 1122-1125
7. Al-Lawati J.A., Mohammed A.J., Al-Hinai H.Q., and Jousilahti P. Prevalence of the metabolic syndrome among Omani adults. Diabetes Care 26 6 (2003) 1781-1785
8. Deeks J.J., and Altman D.G. Diagnostic tests 4: likelihood ratios. BMJ 329 7458 (2004) 168-179
9. Lu F.H., Yang Y.C., Wu J.S., Wu C.H., and Chang C.J. A population-based study of the prevalence and associated factors of diabetes mellitus in southern Taiwan. Diabet. Med. 15 7 (1998) 564-572
10. Harris M.I., Eastman R.C., Cowie C.C., Flegal K.M., and Eberhardt M.S. Comparison of diabetes diagnostic categories in the U.S. population according to the 1997 American Diabetes Association and 1980-1985 World Health Organization diagnostic criteria. Diabetes Care 20 12 (1997) 1859-1862
11. Wahl P.W., Savage P.J., Psaty B.M., Orchard T.J., Robbins J.A., and Tracy R.P. Diabetes in older adults: comparison of 1997 American Diabetes Association classification of diabetes mellitus with 1985 WHO classification. Lancet 352 9133 (1998) 1012-1015
12. Shaw J.E., de Courten M., Boyko E.J., and Zimmet P.Z. Impact of new diagnostic criteria for diabetes on different populations. Diabetes Care 22 5 (1999) 762-766
13. The DECODE study group on behalf of the European Diabetes Epidemiology Study Group. Will new diagnostic criteria for diabetes mellitus change phenotype of patients with diabetes? Reanalysis of European epidemiological data. BMJ 317 7155 (1998) 371-375
14. Wiener K., and Roberts N.B. Diagnostic criteria for diabetes mellitus. Clin. Chem. 44 10 (1998) 2222-2224
15. Anand S.S., Razak F., Vuksan V., Gerstein H.C., Malmberg K., Yi Q., et al. Diagnostic strategies to detect glucose intolerance in a multiethnic population. Diabetes Care 26 2 (2003) 290-296
16. Hwu C.M., Kwok C.F., Ku B.I., Lin Y.T., Lee Y.S., Hsiao L.C., et al. Undiagnosed glucose intolerance encountered in clinical practice: reappraisal of the use of the oral glucose tolerance test. Chin. Med. J. (Taipei) 64 8 (2001) 435-442
17. Finch C.F., Zimmet P.Z., and Alberti K.G. Determining diabetes prevalence: a rational basis for the use of fasting plasma glucose concentrations?. Diabet. Med. 7 7 (1990) 603-610
18. The DECODE study group on behalf of the European Diabetes Epidemiology Group, Is fasting glucose sufficient to define diabetes? Epidemiological data from 20 European studies. Diabetes Epidemiology. Collaborative analysis of Diagnostic Criteria in Europe, Diabetologia 42 (6) (1999) 647-654.
19. Modan M., and Harris M.I. Fasting plasma glucose in screening for NIDDM in the U.S. and Israel. Diabetes Care 17 5 (1994) 436-439
20. Pan X.R., Li G.W., Hu Y.H., Wang J.X., Yang W.Y., An Z.X., et al. Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study. Diabetes Care 20 4 (1997) 537-544
21. Tuomilehto J., Lindstrom J., Eriksson J.G., Valle T.T., Hamalainen H., Ilanne-Parikka P., et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N. Engl. J. Med. 344 18 (2001) 1343-1350
22. Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or Metformin. N. Engl. J. Med. 6 346 (2002) 393-403
23. DeFronzo R.A. Lilly lecture 1987. The triumvirate: beta-cell, muscle, liver. A collusion responsible for NIDDM. Diabetes 37 6 (1988) 667-687